Mixed fermentation beverage of elaeagnus angustifolia juice bifidobacterium and lactobacillus paracasei and preparation method of mixed fermentation beverage

By using a microbial combination of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29 for fermentation in jujube juice, the problem of underutilization of the nutritional value of jujube fruit was solved, and the content of functional active ingredients and antioxidant capacity of the juice was significantly improved, which has commercial value.

CN118909843APending Publication Date: 2024-11-08SHIHEZI UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410995712.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing technologies fail to fully utilize the nutritional value of jujube fruit, and simple processing results in significant resource waste, failing to effectively improve the content of functional active ingredients and antioxidant capacity of the juice.

Method used

A microbial combination of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29 was used to ferment jujube juice. The pH value was adjusted and sterilized. Fermentation was carried out for 48 hours to increase the content of flavonoids and polyphenols and enhance the free radical scavenging ability.

Benefits of technology

It significantly increased the content of functional active ingredients in jujube juice, enhanced its antioxidant capacity, and provided broad market prospects and commercial value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909843A_ABST
    Figure CN118909843A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of microbial fermentation, and particularly relates to an elaeagnus angustifolia juice bifidobacterium and lactobacillus paracasei mixed fermentation beverage and a preparation method thereof. The invention provides a microbial composition which is composed of bifidobacterium animalis subsp. Lactis HN-3 and lactobacillus paracasei YL-29, and a preparation method of the microbial composition, which is characterized in that the microbial composition is prepared from lactobacillus plantarum subsp. Lactis HN-3, lactobacillus paracasei YL-29 and lactobacillus paracasei YL-29, and the lactobacillus paracasei YL-29 and the lactobacillus paracasei YL-29 and the lactobacillus paracasei YL-29 are used for preparing the microbial composition. The microbial composition has strong antioxidant activity and acid production capacity, can significantly improve the contents of flavones and polyphenols in plant source active ingredients, converts the plant source active ingredients, increases the content of functional active ingredients in fruit juice, and enhances the free radical scavenging capacity. Finally, pleasant fragrance is generated, and the market prospect is wide.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of food processing, and particularly relates to a mixed bacteria fermented beverage of bifidobacterium and Lactobacillus paracasei from elata juice and a preparation method thereof. Background Art

[0002] In recent years, more and more studies have been conducted on the use of probiotics to ferment fruit juice. For example, invention patent CN108148784A uses a strain of ethanol-resistant Lactobacillus paracasei SMN-LBK to ferment fruit and vegetable juice, invention patent CN104983022A uses a strain of animal Bifidobacterium to ferment fruit and vegetable powder, and invention patent CN113974032A uses mixed bacteria, including Bifidobacterium, Lactobacillus acidophilus and yeast to ferment roxburghii fruit powder to study enzyme drinks that increase the content of human collagen. Juice fermented with probiotics can improve its shelf life and safety, enhance nutritional value and sensory quality, and produce related active substances.

[0003] The fruit of Elaeagnus angustifolia is delicious, slightly sweet and sour, and contains a large number of nutrients, such as sugars, phenolic acids and flavonoids. It has antioxidant, anti-diarrhea, anti-diabetes and anti-inflammatory effects, can treat cancer and viral diseases, improve the damage caused by gastric ulcers, and has a significant inhibitory effect on a variety of bacteria and molds. If Elaeagnus angustifolia is simply processed, it will not only waste a lot of resources, but also fail to maximize the nutritional value of Elaeagnus angustifolia itself.

[0004] The present invention firstly obtains a strain of Bifidobacterium animalis lactis subspecies HN-3 and a strain of Lactobacillus paracasei YL-29 through preliminary research. Both the strains HN-3 and YL-29 can grow stably in elata fruit juice and have strong antioxidant activity and acid production capacity. Secondly, the strains HN-3 and YL-29 are combined to transform plant-derived active ingredients, significantly increase the content of functional active substances, and fully release the activity of the plant. The free radical scavenging ability of the elata fruit juice finally obtained is significantly enhanced. Summary of the invention

[0005] First, the purpose of the present invention is to provide a microbial combination comprising animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29, which can grow stably in Elaeagnus angustifolia juice and has strong antioxidant activity and acid production capacity; secondly, the present invention converts the microbial combination into plant-derived active ingredients, increases the content of functional active ingredients in the fermented Elaeagnus angustifolia juice, enhances the free radical scavenging ability of the juice, enriches the nutritional value of the juice, and has broad market prospects. Specifically including the following contents:

[0006] In the first aspect, the present invention provides a microbial combination, comprising Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29; the Bifidobacterium animalis subsp. lactis HN-3 was deposited in the China Center for Type Culture Collection on July 4, 2022, with a deposit number of CCTCC NO: M 20221023; the Lactobacillus paracasei YL-29 was deposited in the China Center for Type Culture Collection on July 4, 2022, with a deposit number of CCTCC NO: M20221022.

[0007] Preferably, the ratio of Bifidobacterium animalis subspecies lactis HN-3 to Lactobacillus paracasei YL-29 is 1:1.

[0008] In a second aspect, the present invention provides the microbial combination described in the first aspect having any of the following uses:

[0009] (1) Application in food preparation;

[0010] (2) Application in the preparation of food additives;

[0011] (3) Application in the preparation of food starter cultures;

[0012] (4) Application in fruit juice fermentation;

[0013] (5) Application in promoting the transformation of plant-derived antioxidant active ingredients.

[0014] In a third aspect, the present invention provides the use of the microbial combination described in the first aspect in fermenting and preparing an Elaeagnus angustifolia juice rich in flavonoids and polyphenols.

[0015] In a fourth aspect, the present invention provides a method for fermenting an Elaeagnus angustifolia juice rich in flavonoids and polyphenols, the method comprising: fermenting the Elaeagnus angustifolia juice using the microbial combination described in the first aspect.

[0016] Preferably, the method comprises the following steps:

[0017] (1) preparing Elaeagnus angustifolia juice and adjusting the pH of the juice to 7;

[0018] (2) sterilize the juice at 95°C for 5 min;

[0019] (3) Activate the microbial combination described in the first aspect and inoculate it into the sterilized Elaeagnus angustifolia juice in step (2) for fermentation.

[0020] Preferably, the step (1) is: peel and core the Elaeagnus angustifolia and then crush it, mix the Elaeagnus angustifolia powder with water in a ratio of 1:4 (m / v), mix them evenly, and heat them in a boiling water bath for 5 minutes; filter, and adjust the pH of the juice to 7 with edible alkali to obtain Elaeagnus angustifolia juice.

[0021] Preferably, the step (3) is: taking the activated microbial combination of claim 1, inoculating it into the sterilized Elaeagnus angustifolia juice in step (2) at an inoculation rate of 1% (v / v) of a single bacterium, and culturing it in a constant temperature anaerobic box at 37°C for 48 hours for fermentation.

[0022] In a fifth aspect, the present invention provides an Elaeagnus angustifolia juice rich in flavonoids and polyphenols, wherein the Elaeagnus angustifolia juice rich in flavonoids and polyphenols is obtained by fermenting using the method described in the fourth aspect.

[0023] In a sixth aspect, the present invention provides a use of the Elaeagnus angustifolia juice rich in flavonoids and polyphenols as described in the fifth aspect in the preparation of antioxidant health products or health foods.

[0024] The beneficial effects of the present invention are:

[0025] (1) The present invention provides a microbial combination of Bifidobacterium animalis subspecies lactis HN-3 and Lactobacillus paracasei YL-29; the microbial combination can grow stably in Elaeagnus angustifolia juice and has antioxidant and acid-producing activities;

[0026] (2) The microbial combination transforms the plant-derived active ingredients to synergistically improve the free radical scavenging ability, and the content of functional active substances is significantly increased; in addition, the results of non-target metabolomics analysis show that the metabolically upregulated substances also contain many other functional active substances, indicating that the fermented product of the present invention has a good application prospect; at the same time, most of the phenolic substances and flavonoids in these functional active substances have anti-cancer, anti-tumor, anti-hypertension, anti-diabetes, antibacterial, immune-enhancing and other disease-preventing effects, which indicates that the fermented Elaeagnus angustifolia juice can be further developed and used as a medicinal functional beverage for consumption;

[0027] (3) Considering the wide planting area of ​​Elaeagnus angustifolia in Xinjiang, simple processing and low cost, Elaeagnus angustifolia fermented juice has great commercial value and market potential, and has a higher development value. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0029] Figure 1 The growth of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice, where B.an3 is Bifidobacterium animalis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is a combined fermentation of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29;

[0030] Figure 2 Acid production curve of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice, wherein B.an3 is Bifidobacterium animalis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is a combined fermentation of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29;

[0031] Figure 3 The total phenol content changes of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice fermented for 48 hours, where B.an3 is Bifidobacterium animalis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is the combined fermentation of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29;

[0032] Figure 4 The change of total flavonoids content of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice after fermentation for 48 hours, where B.an3 is Bifidobacterium animalis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is the combined fermentation of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29;

[0033] Figure 5 ABTS free radical scavenging rate of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice fermented for 48 hours, where B.an3 is Bifidobacterium animalis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is a combined fermentation of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29;

[0034] Figure 6 DPPH free radical scavenging rate of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice fermented for 48 hours, where B.an3 is Bifidobacterium animalis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is a combined fermentation of Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29;

[0035] Figure 7The principal component analysis diagram of the elata juice of different fermentation groups and the unfermented elata juice, among which EWJB is the elata juice fermented by Bifidobacterium animalis subspecies HN-3; EWJL is the elata juice fermented by Lactobacillus paracasei YL-29; EWJBL is the elata juice fermented by Bifidobacterium animalis subspecies HN-3 and Lactobacillus paracasei YL-29; EWJK is the unfermented elata juice;

[0036] Figure 8 The changes in the quantity of different types of metabolites between different fermentation groups and the control group, among which EWJB is the fruit juice fermented by Bifidobacterium animalis subsp. lactis HN-3; EWJL is the fruit juice fermented by Lactobacillus paracasei YL-29; EWJBL is the fruit juice fermented by Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29; EWJK is the unfermented fruit juice;

[0037] Fig. 9 KEGG-annotated metabolic pathways of differential metabolites in Elaeagnus angustifolia juice fermented by the combination of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29;

[0038] Fig.10 Different functional activities of metabolites with different structures in Elaeagnus angustifolia juice fermented by the combination of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29;

[0039] Fig.11 The main metabolic pathways of differential metabolites in Elaeagnus angustifolia juice fermented by combination of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29. DETAILED DESCRIPTION

[0040] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. Specific conditions are not specified in the embodiments, and the conditions recommended by the manufacturer are carried out according to conventional conditions or manufacturers. The reagents or instruments used without indicating the manufacturer are all conventional products that can be purchased commercially.

[0041] The MRS medium described in the following examples: peptone 10 g, beef extract 10 g, K2HPO4 2 g, glucose 20 g, diammonium citrate 2 g, sodium acetate 5 g, MgSO4.7H2O 0.58 g, MnSO4 0.25 g, Tween 80 1 mL, yeast extract 2 g, agar 20 g, water 1000 mL, L-cysteine ​​0.5 g (1 mL sterile water), mupirocin 0.05 g (500 μL anhydrous ethanol) and vancomycin 0.02 g (1 mL sterile water) were sterilized at 115°C for 20 min.

[0042] Unless otherwise specified, other experimental materials and instruments can be purchased through commercial channels.

[0043] Example 1 Preparation of bacteria and juice

[0044] 1.1 Activation of strains

[0045] Prepare 50 mL of MRS liquid culture medium with L-cysteine ​​and mupirocin and 50 mL of MRS liquid culture medium with L-cysteine ​​and vancomycin, sterilize them with high pressure steam at 115°C for 20 min, use a pipette to pipette 900 μL of MRS liquid culture medium containing L-cysteine ​​and mupirocin into a 1.5 mL EP tube, add 100 μL of Bifidobacterium animalis subsp. lactis HN-3 bacterial solution, similarly, use a pipette to pipette 900 μL of MRS liquid culture medium containing L-cysteine ​​and vancomycin into a 1.5 mL EP tube, add 100 μL of Lactobacillus paracasei YL-29 bacterial solution, and finally culture them in a constant temperature anaerobic box at 37°C for 48 h.

[0046] 1.2 Strain preservation

[0047] Prepare 75% glycerol and MRS liquid culture medium (HN-3: add cysteine ​​and mupirocin, YL-29: add cysteine ​​and vancomycin) and sterilize at 115°C for 20 minutes. Centrifuge the activated bacterial solution for 48 hours at 8000rpm / min for 5 minutes, discard the supernatant, add 1mL of MRS liquid culture medium, shake well, resuspend the bacterial solution in a 2mL storage tube containing 500μL 75% glycerol, and store it at -20°C.

[0048] 1.3 Preparation of Elaeagnus angustifolia juice

[0049] The Elaeagnus angustifolia used in the present invention is obtained from the Kashgar region of Xinjiang. The edible Elaeagnus angustifolia fruit is mostly characterized by shrunken epidermis, low water content, powdery flesh, and light yellow color. The Elaeagnus angustifolia is peeled and pitted, and the Elaeagnus angustifolia powder is mixed with water at a ratio of 1:4 (m / v), stirred evenly, heated in a boiling water bath for 5 minutes, and filtered (filtered through a 400-mesh gauze) to obtain Elaeagnus angustifolia juice. The Elaeagnus angustifolia juice finally appears slightly yellow and contains a small amount of sediment.

[0050] The pH of the juice was adjusted to 7 using edible alkali and sterilized at 95°C for 5 min.

[0051] Embodiment 2 Fermentation of Elaeagnus angustifolia fruit juice

[0052] 2.1 Fermentation process

[0053] The activated animal Bifidobacterium lactis subsp. HN-3 and Lactobacillus paracasei YL-29 were examined under an inverted microscope. When all rods were observed, the OD was adjusted with physiological saline. 600 The bacterial solution concentration reached 0.8, and the mixed bacteria were inoculated into the sterilized Elaeagnus angustifolia juice at a 1% (v / v) inoculation amount, and cultured in a constant temperature anaerobic box at 37°C for 48 hours.

[0054] 2.2 Detection of strain growth performance after fermentation of Elaeagnus angustifolia juice

[0055] Method: The activated animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 were examined under an inverted microscope. When all rods were observed, the OD was adjusted with physiological saline. 600 The bacterial solution concentration was made to reach 0.8, and the mixed bacteria were inoculated into the sterilized Elaeagnus angustifolia juice at a 1% (v / v) inoculum, and cultured in a 37°C constant temperature anaerobic box for 48 hours. Samples were taken at 0h, 12h, 24h, 36h, and 48h, and the absorbance of the juice was detected at 600nm using an enzyme marker. The bacterial solution at each time point was diluted 10 -1 , 10 -3 , 10 -5 100 μL of bacterial solution was respectively applied on MRS solid medium to count live bacteria. A pH meter was used to measure the pH at each time period. Growth curves and acid production curves were drawn based on the total number of live bifidobacteria and pH value. Each group of experiments was repeated three times.

[0056] Results: The viable bacteria count showed that the growth changes of Bifidobacterium animalis subspecies lactis HN-3 and Lactobacillus paracasei YL-29 in Elaeagnus angustifolia juice were as follows: Figure 1 As shown in the figure, the total amount of bacteria in the elm date juice fermented by animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 alone and in the combined fermentation of elm date juice after culturing at 37°C for 48 hours generally showed an upward trend. Among them, the growth of animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 combined fermentation was better, from the initial 0.78×10 8 The CFU / mL increased to 1.65×10 8 CFU / mL, the number increased by 47.8%. And when fermenting juice, the fermented strain needs to have the ability to grow in juice up to 10 8 CFU / mL, it is worth developing products. Therefore, the combination of animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 has the advantage of stable growth. In addition, the acid production curve is as follows Figure 2As shown, after the single bacteria and combined fermentation of animal bifidobacterium lactis subspecies HN-3 and lactobacillus paracasei YL-29, pH generally shows a downward trend. In the early stage of fermentation, probiotics can significantly reduce the pH value of juice, produce an appropriate amount of CO2, thereby inhibiting the growth of non-lactic acid bacteria or spore bacteria. Among them, the acid resistance of the elm date juice fermented by animal bifidobacterium lactis subspecies HN-3 and lactobacillus paracasei YL-29 is the strongest, and pH can reach 3.88 after fermentation 48h. It can be seen from the change of cell growth and pH that the combination of animal bifidobacterium lactis subspecies HN-3 and lactobacillus paracasei YL-29 fermented elm date juice is the best effect compared to the strain fermentation alone.

[0057] 2.3 Changes in total phenol content at 48 h of fermentation

[0058] Extraction of total phenols: Take 10 mL of juice and add it to a 100 mL volumetric flask, add 75% anhydrous ethanol to make up the volume. After standing for 1 hour in the dark, take it out and centrifuge it at 5000 rpm / min for 5 minutes, take the supernatant and make up the volume again to a 100 mL volumetric flask.

[0059] Determination of total phenol: Take 1mL of the extract diluent in a 25mL colorimetric tube, add 10mL of distilled water, shake well, add 1.5mL of Folin phenol reagent, shake well, immediately add 6mL of 10% Na2CO3 solution, mix well, add water to make up to volume, mix well again, and then place at 30°C in the dark for 2h. Use the reagent sample as blank and measure the absorbance at a wavelength of 765nm with an enzyme marker. According to the standard curve equation y=-0.03528+0.00858x(R 2 =0.99305) to calculate the polyphenol content in the extract (in terms of gallic acid, mg (GAE) / L), and the polyphenol content was obtained by further calculation.

[0060] Results: Figure 3 As shown, the total phenol content in the elm fruit juice after fermentation for 48 hours is rising. However, at 48 hours of fermentation, the polyphenol content in the elm fruit juice fermented by animal Bifidobacterium lactis subspecies HN-3 is not as good as the polyphenol content in the elm fruit juice fermented by Lactobacillus paracasei YL-29, and the difference between the two is 9.4 mg (GAE) / L, while the total phenol content of the elm fruit juice fermented by animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 reached 159 mg (GAE) / L, which is significantly higher than the total phenol content after fermentation alone. This shows that the combination of animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 can significantly increase the polyphenol content in elm fruit juice.

[0061] 2.4 Changes in total flavonoid content at 48 h of fermentation

[0062] Method: 500 μL of fermented juice and unfermented juice were transferred to separate test tubes, and 1.5 mL of methanol, 0.1 mL of 10% aluminum chloride, 0.1 mL of 1 mol / L potassium acetate, and 2.8 mL of distilled water were added. After incubation at room temperature for 30 min, the absorbance of the reaction mixture was measured by spectrophotometry at 415 nm. Rutin was used as the standard compound, and the standard curve y = 0.015x + 0.025 (R 2 =0.9991) to calculate the total flavonoid content in the extract (in terms of rutin, mg(RE) / L), and the total flavonoid content was obtained by further calculation.

[0063] Results: Figure 4 As shown, the total flavonoid content in the elm fruit juice after fermentation for 48 hours is rising. However, at 48 hours of fermentation, the total flavonoid content in the elm fruit juice fermented by animal Bifidobacterium lactis subspecies HN-3 (129.8mg (RE) / L) is similar to the total flavonoid content in the elm fruit juice fermented by Lactobacillus paracasei YL-29 (127.4mg (RE) / L), and the difference between the two is only 2.4mg (RE) / L. However, the total flavonoid content in the elm fruit juice fermented by animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 reached 134.5mg (RE) / L, which was significantly improved compared to the separate fermentation of the two strains. This shows that the combination of animal Bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 can significantly increase the total flavonoid content in the elm fruit juice.

[0064] 2.5 Changes in antioxidant activity during 48 h of fermentation

[0065] Determination of ABTS free radical scavenging rate: First, prepare 7mM ABTS working solution, that is, accurately weigh 3mg ABTS, dilute to 0.8mL with distilled water, then weigh 1mg potassium persulfate and dissolve it in 1.5mL distilled water to make 2mM potassium persulfate aqueous solution, and then mix it to 1.6mL in a ratio of 1 (0.8mL): 1 (0.8mL). Place it at room temperature and avoid light for 12-16h, dilute it with distilled water and adjust the absorbance to 0.700±0.005 for use. Add 200μL of sample to 800μL ABTS working solution, let it stand for 6min, and measure the absorbance at 734nm with an enzyme marker. The results are expressed as Trolox equivalents (μmol TE / 100g juice) per 100g juice.

[0066]

[0067] Where: A0-absorbance of distilled water and ABTS working solution at 734nm; A j -Absorbance of fermentation broth and ABTS working solution at 734 nm.

[0068] Results: The results of ABTS free radical scavenging rate are as follows: Figure 5 As shown, after fermentation for 48h, the ABTS free radical scavenging rate of the combined fermentation of the elm date fruit juice by animal bifidobacterium lactis subspecies HN-3 and lactobacillus paracasei YL-29 was significantly greater than the ABTS free radical scavenging rate of the elm date fruit juice after the two strains were fermented separately. The ABTS free radical scavenging rate of the combined fermentation elm date fruit juice reached 98.12%, which was significantly increased by 17.14% compared to the elm date fruit juice fermented by animal bifidobacterium lactis subspecies HN-3, and significantly increased by 7.06% compared to the elm date fruit juice fermented by lactobacillus paracasei YL-29. The results show that the elm date fruit juice fermented by the combined fermentation of animal bifidobacterium lactis subspecies HN-3 and lactobacillus paracasei YL-29 of the present invention significantly improves the ABTS free radical scavenging rate of the fruit juice during single bacterial fermentation, thereby indicating that the fermented elm date fruit juice has the potential to become a good antioxidant activity product. At the same time, consistent with the increase of total phenol content and total flavonoid content, the ABTS free radical scavenging rate in the elm date fruit juice after fermentation for 48h under the combined action of the two strains is the same as the change trend of the content of functional active ingredients.

[0069] Determination of DPPH free radical scavenging rate: Prepare 1mM DPPH solution, accurately weigh 39.4mg of DPPH reagent, dissolve it in 95% ethanol solution and then dilute it to 100mL in a volumetric flask, place it in a refrigerator at 0-4℃, keep it away from light, and use it immediately after preparation. Use anhydrous methanol as a blank, mix 2mL of anhydrous methanol with 0.5mL of DPPH solution, react at room temperature away from light for 30min, and use a spectrophotometer to measure A at a wavelength of 517nm. c 2 mL of sample solution was mixed with 0.5 mL of DPPH solution, and the mixture was reacted at room temperature for 30 min in the dark. A was measured at a wavelength of 517 nm using a spectrophotometer. i 2 mL of sample solution was mixed with 0.5 mL of anhydrous methanol, and the mixture was reacted at room temperature for 30 min in the dark. A was measured at a wavelength of 517 nm using a spectrophotometer. j . Calculate the DPPH free radical scavenging rate according to the formula.

[0070]

[0071] Where: A i A is the absorbance after the fermented juice reacts with the DPPH free radical solution; j A is the absorbance of the mixture of fermented juice and anhydrous methanol; c It is the absorbance of the mixture of anhydrous methanol and DPPH solution.

[0072] Results: The DPPH free radical scavenging rate results are as follows Figure 6As shown, the DPPH free radical scavenging rate (90.22%) after fermentation of Elaeagnus angustifolia juice by animal bifidobacterium lactis subspecies HN-3 was significantly increased by 20.69% compared with the DPPH free radical scavenging rate (69.53%) after fermentation of Elaeagnus angustifolia juice by Lactobacillus paracasei YL-29. This indicates that animal bifidobacterium lactis subspecies HN-3 is more sensitive to DPPH free radicals. And under the combined fermentation of animal bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29, the DP PH free radical scavenging rate reached 95.18% after 48 hours, which was significantly improved compared with the DPPH free radical scavenging rate of the strain fermented alone.

[0073] In summary, the results of ABTS free radical scavenging rate and DPPH free radical scavenging rate showed that animal Bifidobacterium lactis subsp. HN-3 was more sensitive to DPPH free radical binding, and Lactobacillus paracasei YL-29 was more sensitive to ABTS free radical binding. However, the scavenging rate of both ABTS free radical and DPPH free radical in the elm date juice fermented under the combined action of animal Bifidobacterium lactis subsp. HN-3 and Lactobacillus paracasei YL-29 was significantly improved.

[0074] Example 3 Non-target metabolomics analysis of combined fermentation of Elaeagnus angustifolia juice

[0075] (1) Extraction of metabolites

[0076] Methods: Place the sample (100 μL) in an EP tube, add 400 μL of pre-cooled 80% methanol and vortex thoroughly to resuspend. Then incubate the sample on ice for 5 minutes and centrifuge at 15,000 g, 4°C for 20 minutes. Dilute part of the supernatant with LC-MS grade water to a final methanol content of 53%, then transfer the sample to a new EP tube and centrifuge at 15,000 × g at 4°C for 20 minutes. Finally, inject the supernatant into the LC-MS / MS system for analysis.

[0077] (2) UHPLC-MS / MS analysis

[0078] The sample was injected through a HypesilGold C18 column (100×2.1 mm, 1.9 μm) with a linear gradient injection for 17 min at a flow rate of 0.2 mL / min. The eluents in the positive polarity mode were eluent A (0.1% formic acid in water) and eluent B (methanol), and the eluents in the negative polarity mode were eluent A (5 mM ammonium acetate, pH 9.0) and eluent B (methanol): 2% B, 1.5 min; 2-85% B, 3 min; 85-100% B, 10 min; 100-2% B, 10.1 min; 2% B, 12 min. The QExactiveTM high frequency mass spectrometer used positive / negative polarity mode, with a spray voltage of 3.5 kV, a capillary temperature of 320 °C, a sheath gas flow rate of 35 psi, an auxiliary gas flow rate of 10 L / min, an S-lens RF level of 60, an auxiliary gas heater temperature of 350 °C, and a scan range of 100-1500 m / z.

[0079] (3) Data analysis and metabolite identification

[0080] Methods: Compound Discoverer 3.1 (CD3.1, ThermoFisher) was used to process the raw data files generated by ultra-high performance liquid chromatography-mass spectrometry / mass spectrometer. Each metabolite was simply screened by retention time and mass-to-charge ratio, and peak alignment, peak selection and quantification were performed with retention time tolerance of 0.2 minutes; actual mass tolerance of 5ppm; signal intensity tolerance of 30%; signal-to-noise ratio of 3; and minimum intensity as the main parameters. Then the peak intensity was normalized to the total spectrum intensity, and then the molecular formula was predicted based on the normalized data according to the addition ion, molecular ion peak and fragment ion. Comparison with mzCloud (https: / / www.mz cloud.org / ), mzVault and MassList databases was performed to obtain accurate quantitative and relative quantitative results. Statistical analysis was then performed to finally obtain the identification and relative quantitative results of the metabolites.

[0081] Mass spectrometry data acquisition and quantitative analysis of target compounds were completed using SCIEX Analyst Work Station Software (Version 1.6.3). MSconventer software was used to convert the raw mass spectrometry data into TXT format. Then, a self-written R package was used in combination with a self-built database to complete peak extraction and annotation. A comprehensive analysis of differential metabolites was conducted in combination with changes in functional activity, and a material metabolic network was drawn to analyze the material transformation related to functional activity.

[0082] Results: Non-target metabolomics analysis of four groups of Elaeagnus angustifolia juices, including fermentation with animal Bifidobacterium lactis subsp. HN-3, fermentation with Lactobacillus paracasei YL-29, combined fermentation with animal Bifidobacterium lactis subsp. HN-3 and Lactobacillus paracasei YL-29, and non-fermentation, was performed by UHPLC-MS / MS technology, and 1316, 1320, 1293, and 1312 substances were detected, respectively. These substances include: lipids and lipid molecules, organic acids and their derivatives, phenylacetone and polyketone compounds, organic heterocyclic compounds, organic oxygen compounds, benzene, nucleosides, nucleotides and analogs, organic nitrogen compounds, alkaloids and their derivatives, homogeneous non-metallic compounds, hydrocarbon derivatives, lignans, neolignans and related compounds, and other types of substances. The principal component analysis is shown in the figure below. Figure 7 As shown, the results showed that the sample groups were closely clustered together, and the Elaeagnus angustifolia juices after single and combined fermentation could be significantly separated on PC1 and PC2 compared with the unfermented juice, which indicated that both single-bacteria fermentation and combined fermentation had a significant impact on the metabolites of Elaeagnus angustifolia juice.

[0083] As shown in Table 1 (wherein, B.an3 is animal bifidobacterium lactis subspecies HN-3; L.cp29 is Lactobacillus paracasei YL-29; B3L29 is animal bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 combined fermentation, K is before fermentation), in the comparison between animal bifidobacterium lactis subspecies HN-3 fermented juice and unfermented juice, a total of 374 differential metabolites were identified, of which 190 differential metabolites were up-regulated and 184 differential metabolites were down-regulated. In the comparison between Lactobacillus paracasei YL-29 fermented juice and unfermented juice, a total of 249 differential metabolites were identified, of which 107 were up-regulated and 142 were down-regulated. However, in the comparison between animal bifidobacterium lactis subspecies HN-3 and Lactobacillus paracasei YL-29 combined fermented juice and unfermented juice, a total of 428 differential metabolites were identified, of which 172 were up-regulated and 256 were down-regulated. It can be seen that the combined fermentation has a more significant effect on the juice. Therefore, the differential metabolites of the comparison group were further analyzed.

[0084] Table 1 Changes of differential metabolites in different fermented Elaeagnus angustifolia juice comparison groups

[0085]

[0086] In addition, all the differential metabolites in the three fermentation groups were classified into seven major categories, namely carboxylic acid compounds, lipid compounds, organic oxygen compounds, benzene compounds, nucleic acid compounds, phenylpropanoid compounds and other substances. Carboxylic acid substances are mainly carbohydrates, organic oxygen compounds are mainly amino acids, nucleic acid compounds mainly include pyrimidine and purine, and flavonoids account for the highest proportion of phenylpropanoid compounds.

[0087] like Figure 8 As shown, EWJB represents the elata fruit juice fermented by the strain Bifidobacterium animalis subspecies lactis HN-3, EWJL represents the elata fruit juice fermented by the strain Lactobacillus paracasei YL-29, and EWJBL represents the elata fruit juice fermented by the strain Bifidobacterium animalis subspecies lactis HN-3 and Lactobacillus paracasei YL-29 combination. The results show that the number of lipid compounds is the largest in the three fermentation groups, and the number of the strain combination fermentation group is the highest. In addition, except that the number of benzene compounds and nucleic acid compounds is low, the number of the strain combination fermentation comparison group in the other four types of substances is higher than that of the strain fermentation group. Therefore, compared with fermentation alone, the strain combination fermentation can more widely affect different carbohydrates, lipid compounds, amino acids, purines, pyrimidines and flavonoids, thereby increasing the functional active ingredients and improving the antioxidant activity of the juice.

[0088] In summary, for the elata fruit juice fermented by the combination of the strains Bifidobacterium animalis subspecies lactis HN-3 and Lactobacillus paracasei YL-29, a KEGG database comparison was further performed, such as Fig. 9 As shown in the figure, 155 differential metabolites of the combined fermentation group of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29 were annotated to 158 metabolic pathways. The results showed that the most annotated major category of differential metabolites was metabolism, especially amino acid metabolism, biosynthesis of secondary metabolites, nucleic acid metabolism, carbohydrate metabolism, lipid metabolism and energy metabolism. The second largest category was the organism system, especially the digestive system. Compared with the annotation results of the fermentation of Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29, the annotation results of the combined fermentation of the strains also added 3 organism systems (aging, environmental adaptation and excretion system pathways), 1 cellular process (cell colony pathway), 1 drug development (anti-tumor drug pathway) and 3 environmental information processes (membrane transport, signal transduction, signal molecules and interactions).

[0089] like Fig.10 As shown in the figure, some of the differential metabolites produced during the fermentation of Elaeagnus angustifolia juice by the combination of the strains Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29 have different structures and thus exhibit different functional activities, such as antioxidant, anti-inflammatory, anti-tumor and antibacterial. Fig.11 As shown in the fermentation process, metabolic transformation leads to the mutual transformation of these differential metabolites, resulting in changes in the structure of the bioactive components. As for functional activity, the focus is on the antioxidant activity represented by flavonoids, which mainly undergo material transformation between four types of different structures under the combined fermentation of the strains Bifidobacterium animalis subspecies lactis HN-3 and Lactobacillus paracasei YL-29.

[0090] As shown in Table 2, there is a certain conversion relationship between flavonoid glycosides and flavonoid aglycones. And under the premise that both flavonoid glycosides and flavonoid aglycones have antioxidant, anti-tumor and anti-inflammatory functional activities, the study found that flavonoid aglycones are easier to be absorbed by the human body and their bioavailability is significantly improved. As shown in Table 3, many demethylated flavonoids have higher functional activities than their methylated precursors, such as anti-inflammatory, antioxidant and anti-tumor activities. Therefore, the increase in their content is a further development of antioxidant active products. As for flavonoids and flavonoids with other structures through redox reactions, as shown in Tables 4 and 5, the functional activities of some flavonoid precursors are weaker than those of the products. For example, previous studies have shown that as a direct scavenger of reactive oxygen species, eriodictyol is a better antioxidant than naringenin. Due to the presence of two hydroxyl groups on the B ring, eriodictyol exhibits higher antioxidant activity than naringenin. Therefore, the combined fermentation of the strains Bifidobacterium animalis subspecies lactis HN-3 and Lactobacillus paracasei YL-29 with the Elaeagnus angustifolia juice can be further developed and utilized as an antioxidant activity product.

[0091] Table 2 Conversion reactions of glycosylated flavonoids

[0092]

[0093] Table 3 Conversion reaction of methoxylated flavonoids

[0094]

[0095] Table 4 Redox reactions between flavonoids

[0096]

[0097] Table 5 Other transformation reactions between flavonoids

[0098]

[0099] The embodiments of the present invention are described above, but the present invention is not limited to the above-mentioned specific implementation modes. The above-mentioned specific implementation modes are merely illustrative and not restrictive. Under the guidance of the present invention, ordinary technicians in the field shall fall within the protection of the present invention without departing from the scope of protection of the purpose of the present invention and the claims.

Claims

1. A microbial combination, characterized in that: The microbial combination includes Bifidobacterium animalis subsp. lactis HN-3 and Lactobacillus paracasei YL-29; the Bifidobacterium animalis subsp. lactis HN-3 was deposited in the China Center for Type Culture Collection on July 4, 2022, with a preservation number of CCTCC NO: M 20221023; the Lactobacillus paracasei YL-29 was deposited in the China Center for Type Culture Collection on July 4, 2022, with a preservation number of CCTCC NO: M20221022.

2. The microbial combination according to claim 1, characterized in that The ratio of the Bifidobacterium animalis subspecies lactis HN-3 to the Lactobacillus paracasei YL-29 is 1:

1.

3. The microbial combination according to claim 1 or 2 has any of the following uses: (1) Application in food preparation; (2) Application in the preparation of food additives; (3) Application in the preparation of food starter cultures; (4) Application in fruit juice fermentation; (5) Application in promoting the transformation of plant-derived antioxidant active ingredients.

4. Use of the microbial combination as described in claim 1 or 2 in fermenting and preparing Elaeagnus angustifolia juice rich in flavonoids and polyphenols.

5. A fermentation method for Elaeagnus angustifolia juice rich in flavonoids and polyphenols, characterized in that: The method comprises: fermenting the Elaeagnus angustifolia juice using the microbial combination described in claim 1 or 2.

6. The method according to claim 5, characterized in that The method comprises the following steps: (1) preparing Elaeagnus angustifolia juice and adjusting the pH of the juice to 7; (2) Sterilize the juice at 95°C for 5 min; (3) Activate the microbial combination described in claim 1 or 2, and inoculate it into the sterilized Elaeagnus angustifolia juice in step (2) for fermentation.

7. The method according to claim 6, characterized in that The step (1) comprises: peeling and removing the core of the Elaeagnus angustifolia and then crushing the Elaeagnus angustifolia powder and water in a ratio of 1:4 (m / v), mixing the mixture evenly, and heating the mixture in a boiling water bath for 5 minutes; filtering the mixture, and adjusting the pH of the juice to 7 with edible alkali to obtain Elaeagnus angustifolia juice.

8. The method according to claim 6, characterized in that The step (3) is: taking the activated microbial combination of claim 1, inoculating it into the sterilized Elaeagnus angustifolia juice in step (2) at an inoculum amount of 1% (v / v) of the mixed bacteria, and culturing it in a constant temperature anaerobic box at 37°C for 48 hours for fermentation.

9. A flavonoid- and polyphenol-rich Elaeagnus angustifolia juice, characterized in that: The Elaeagnus angustifolia juice rich in flavonoids and polyphenols is obtained by fermenting using the method described in any one of claims 5-8.

10. Use of the Elaeagnus angustifolia juice rich in flavonoids and polyphenols as claimed in claim 9 in the preparation of antioxidant health products or health foods.